Paxil Birth Defect Claimant Didn't Show Concealment Was Aimed At Her, Panel Says

Paxil Birth Defect Claimant Didn't Show Concealment Was Aimed At Her, Panel Says

PHILADELPHIA - A claim by a woman who alleges that she had a therapeutic abortion because the antidepressant Paxil caused a heart defect in her unborn son missed a two-year statute of limitations and failed to show that the manufacturer fraudulently concealed the drug's birth defect risk, a Pennsylvania appeals court panel ruled Nov. 17 (Joanne Thomas, et al. v. Smith Kline Beecham Corporation, et al., No. 2461 EDA 2012, Pa. Super.).

Find full version on lexis Advance®
Access this news story on lexis.com®